Ranking · Unmet Need
Trial Gap Index
Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.
Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics
| Rank | Δ | Cancer | Trial Gap Index (percentile points) | Percentile | Confidence | Sources | Why #n? |
|---|---|---|---|---|---|---|---|
| 1 | = | Malignant Colon Neoplasm | +52 | 100 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2591991 |
| 2 | = | Cutaneous Melanoma | +24 | 96 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2591992 |
| 2 | = | Malignant Bladder Neoplasm | +24 | 96 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2591994 |
| 2 | = | Malignant Laryngeal Neoplasm | +24 | 96 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2591993 |
| 5 | = | Malignant Esophageal Neoplasm | +16 | 84 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2591995 |
| 6 | = | Malignant Pancreatic Neoplasm | +12 | 80 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2591996 |
| 6 | = | Malignant Prostate Neoplasm | +12 | 80 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2591997 |
| 8 | = | Malignant Mesothelioma | +8 | 72 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2591998 |
| 8 | = | Malignant Salivary Gland Neoplasm | +8 | 72 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2591999 |
| 8 | = | Malignant Testicular Neoplasm | +8 | 72 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2592000 |
| 11 | = | Malignant Gastric Neoplasm | 0 | 60 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2592001 |
| 11 | = | Malignant Hypopharyngeal Neoplasm | 0 | 60 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2592004 |
| 11 | = | Malignant Kidney Neoplasm | 0 | 60 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2592003 |
| 11 | = | Malignant Lung Neoplasm | 0 | 60 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2592002 |
| 11 | = | Malignant Penile Neoplasm | 0 | 60 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2592005 |
| 16 | = | Hodgkin Lymphoma | -4 | 40 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2592006 |
| 16 | = | Malignant Thyroid Gland Neoplasm | -4 | 40 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2592007 |
| 18 | = | Leukemia | -8 | 32 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2592008 |
| 18 | = | Malignant Rectal Neoplasm | -8 | 32 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2592010 |
| 18 | = | Non-Hodgkin Lymphoma | -8 | 32 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2592009 |
| 21 | = | Malignant Central Nervous System Neoplasm | -12 | 20 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2592011 |
| 21 | = | Malignant Liver Neoplasm | -12 | 20 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2592012 |
| 23 | = | Multiple Myeloma | -16 | 12 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2592013 |
| 24 | = | Malignant Anal Neoplasm | -20 | 8 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2592015 |
| 24 | = | Malignant Nasopharyngeal Neoplasm | -20 | 8 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2592014 |
| 26 | = | Malignant Breast Neoplasm | -80 | 0 | Medium confidence | cdc-uscsclinicaltrialscdc-wonderseeriarc-globocan | inputs
ranking row 2592016 |
Data updated 16 hours agoSource updated unknown26 eligible entities · inputs hash 1499f74e94dd1428d6c4f4a8